AFP also exerts a pro-oncogenic priming in both animal and human models of HCC by reducing the FAS/FAS-associated death domain protein (FADD) apoptotic pathway through the modulation of Human Antigen R RNA-binding protein, resulting in the promotion of tumor growth [65]. This evidence concerns the gene AFP and hepatocellular carcinoma.